NYSE:PLX

Protalix Biotherapeutics Stock Insider Trading

etoro logo Buy PLX
*Your capital is at risk
$2.16
-0.0600 (-2.70%)
At Close: Jun 22, 2026

Protalix BioTherapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.95. In total, the insiders bought 10.51M and sold 168 PLX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.95
Buy 10.51M shares
Sell 168 shares
99% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 19, 2025
Buy
Common Stock
P-Purchase
Bashan Dror
President And CEO
CEO / President 56 000
Value: $101.4K
Nov 18, 2025
Sell
Common Stock
S-Sale
Bar-shalev Amos
Director
Director 168
Value: $314
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Melincoff Gwen A
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Forster Eliot
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Forster Eliot
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Melincoff Gwen A
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Boudes Pol F
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Boudes Pol F
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Schwartz Aharon
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Elze Christian
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Schwartz Aharon
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Elze Christian
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Ben Zvi Shmuel
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Ben Zvi Shmuel
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Stock Options (Right to Buy)
A-Award
Bar-shalev Amos
Director
Director 15 000
Value: $24.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Bar-shalev Amos
Director
Director 7 500
Value: $12.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Naos Yaron
Sr. Vp, Operations
Officer 25 000
Value: $40.0K
Sep 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Naos Yaron
Sr. Vp, Operations
Officer 50 000
Value: $82.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Bashan Dror
President And CEO
CEO / President 195 000
Value: $312.0K
Sep 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bashan Dror
President And CEO
CEO / President 340 000
Value: $557.6K
Sep 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bashan Dror
President And CEO
CEO / President 340 000
Value: $557.6K
Sep 03, 2025
Buy
Common Stock
A-Award
Bashan Dror
President And CEO
CEO / President 195 000
Value: $312.0K
Sep 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Naos Yaron
Sr. Vp, Operations
Officer 50 000
Value: $82.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Naos Yaron
Sr. Vp, Operations
Officer 25 000
Value: $40.0K
Sep 03, 2025
Buy
Common Stock
A-Award
Bar-shalev Amos
Director
Director 7 500
Value: $12.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PROTALIX BIOTHERAPEUTICS INC
Protalix BioTherapeutics
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candi...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE